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The cell-envelope of Mycobacterium tuberculosis
plays a key role in bacterial virulence and antibiotic
resistance. Little is known about the molecular
mechanisms of regulation of cell-envelope for-
mation. Here, we elucidate functional and structural
properties of RNase AS, which modulates
M. tuberculosis cell-envelope properties and
strongly impacts bacterial virulence in vivo. The
structure of RNase AS reveals a resemblance to
RNase T from Escherichia coli, an RNase of the
DEDD family involved in RNA maturation. We show
that RNase AS acts as a 30-50-exoribonuclease that
specifically hydrolyzes adenylate-containing RNA
sequences. Also, crystal structures of complexes
with AMP and UMP reveal the structural basis for
the observed enzyme specificity. Notably, RNase
AS shows a mechanism of substrate recruitment,
based on the recognition of the hydrogen bond
donor NH2 group of adenine. Our work opens a field
for the design of drugs able to reduce bacterial viru-
lence in vivo.
INTRODUCTION
Tuberculosis (TB) is an infectious and often lethal disease whose
threat encountered a resurgence due to spreading of drug-resis-
tant strains (Hett and Rubin, 2008). The causal agent of TB is
Mycobacterium tuberculosis that exists in its human host in a
variety of physiological states including a latent infection
affecting one-third of the world’s population (Chao and Rubin,
2010; Squeglia et al., 2011). The chronic character of the dis-
ease, coupled to the insensitivity of mycobacteria to many anti-
biotics, makes TB a colossal public health problem. For this
reason, the development of new and effective therapies target-
ing essential biosynthetic pathways of mycobacteria is an urgentStructure 22need. A compelling strategy that offers potential for improving
TB therapy is the use of multidrug cocktails acting together using
different mechanisms of action to quickly kill mycobacteria. In
this context, targeting the mycobacterial cell envelope biosyn-
thesis is a cornerstone of TB therapy, as the complex cell enve-
lope of M. tuberculosis is a key component for mycobacterial
survival in the host and virulence of envelope mutants is severely
attenuated in vivo (Brennan and Crick, 2007). The envelope con-
sists of three parts: the cytoplasmic membrane, a peptido-
glycan-arabinogalactan complex covalently linked to mycolic
acids that form a second membrane (the mycomembrane),
and finally an overlaying capsule (Brennan and Nikaido, 1995;
Hoffmann et al., 2008). The outermost layer of the cell envelope,
the capsule, is a network of polysaccharides, i.e., a-glucan,
arabinomannan, and a minority of glycolipids and proteins
(Lemassu and Daffe´, 1994; Ortalo-Magne´ et al., 1995; Sani
et al., 2010). Several of these components are associated
with, or mediate binding to, host cells and modulate immune
responses (Berisio, 2012; Daffe´ and Etienne, 1999; Esposito
et al., 2008; Gagliardi et al., 2007; Stokes et al., 2004). Therefore,
understanding the molecular mechanisms of the cell envelope
formation and its role in host-pathogen interaction is vital for
future antituberculosis drug development.
In the framework of an ongoing project on structural and
functional properties of mycobacterial cell wall components
(Correale et al., 2013; Squeglia et al., 2013), we show here that
deletion of a single gene in the genome of Mycobacterium
marinum (MMAR_3223), a widely used model organism for
M. tuberculosis (Bouley et al., 2001; Broussard and Ennis,
2007), affects mycobacterial cell surface properties in vitro and
virulence in vivo in the zebrafish model. MMAR_3223 has been
shown to be upregulated inside granulomas during long-term
frog infection by M. marinum (Chan et al., 2002), whereas its
ortholog inM. tuberculosis, rv2179c, is essential for mycobacte-
rial growth (Sassetti et al., 2003) and upregulated in the hyper
virulent Beijing strains ofM. tuberculosis during macrophage in-
fections (Alonso et al., 2011). However, the exact role played by
this gene in mycobacterial pathogenicity is hitherto unknown.
In this work, we use a plethora of structural biology, biochem-
ical, and microbiological techniques to characterize the protein, 719–730, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 719
Figure 1. Effect of Inactivation of MMAR_3223 on Virulence of
M. marinum in the Zebrafish Embryo
Mcherry expressingM. marinum (Mma20) WT orMMAR_3223::Tnmutant live
bacteria were injected into zebrafish embryos and the bacterial infection
monitored by fluorescence or plating. Inactivation of MMAR_3223 leads to
attenuation in virulence.
(A and B) Bright-field (left) and fluorescent (right) pictures of 5 days post-
infection (dpi) embryos infected with M. marinum WT (A) or (B) mutant
MMAR_3223::Tn bacteria. The bacterial injection inocula were 161 and 169
CFU, respectively.
(C) Quantification of infection with M. marinum WT or MMAR_3223::Tn in
embryos at 5 dpi. The fluorescence intensities were quantified by proprietary
imaging software and SEM are shown.
(D) Infection ofM.marinumWT,MMAR_3223::Tnmutant andMMAR_3223::Tn
complemented with M. tuberculosis rv2179c, measured by CFU plating of 5
dpi old zebrafish embryos. Each data point represents the CFU count of one
infected embryo. The CFU counts are graphically displayed in a log scale.
Means are represented with bars and mean values are shown in numbers. The
embryos were inoculated with 63, 47, and 62 CFU for WT, mutant, and com-
plementant, respectively; **p < 0.00004, unpaired Student’s t test. Clearly,
inactivation of M. marinum MMAR_3223 leads to a strong attenuation in vivo
and this can be complemented withM. tuberculosis rv2179c (the gene product
of which is RNase AS).
See also Figures S1 and S2 and Tables S1 and S2.
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Structure and Function of Mycobacterial RNase ASencoded by rv2179c. By combining X-ray crystallography and
high performance liquid chromatography (HPLC) analyses, we
prove that this protein is a ribonuclease with strong specificity
for polyadenylate sequences; therefore we denote it as
A-specific RNase (RNase AS). Consistently, the crystal structure
shows that RNase AS shares a similar fold with RNase T from
Escherichia coli, despite the low amino acid sequence identity
between the two proteins. Moreover, the structures of RNase
AS complexes with AMP and UMP provide key information on
the protein:ligand interactions important for catalytic function.
Importantly, these data deliver a clear structural basis to explain720 Structure 22, 719–730, May 6, 2014 ª2014 Elsevier Ltd All rightsthe enzyme specificity, as they identify the critical molecular
requirement of its substrates. This work highlights an important
role for RNase AS in themodulation of cell envelope composition
as well as bacterial virulence in vivo. Based on our structural
data, targeted inhibition of RNase AS can be achieved by small
molecule inhibitors that selectively bind the enzyme catalytic
cleft.
RESULTS
RNase AS Modulates Mycobacterial Cell Envelope
Properties
We created transposon (Tn) mutant libraries in M. marinum
(a model organism for M. tuberculosis) and M. smegmatis and
screened in a double filter assay for mutants with altered produc-
tion of capsular glucan. Using an antiglucan monoclonal anti-
body, we identified several capsular glucan mutants (Table S1
available online). The list shows selected mutants, one of them
is strain MMAR_3223::Tn, expressing less capsular a-glucan in
double filter assay. As compared to wild-type (WT) strain, this
mutant grew slower in vitro both on solid medium and in liquid
culture (Figure S1). In a similar screen on Tn mutants in
M. smegmatis, we isolated one mutant oversecreting capsular
glucan where the Tn insertion was located in MSMEG_4245.
Interestingly, MSMEG_4245 and MMAR_3223 have an ortholog
in the M. tuberculosis genome. As anticipated in the Introduc-
tion, this gene encodes for a protein we denoted as RNase AS.
This protein is predicted to be essential for M. tuberculosis
growth in vitro and hence cannot be inactivated in that
species (Sassetti et al., 2003). Therefore, we focused on
MMAR_3223::Tn as a knockout strain, because the gene prod-
uct ofMMAR_3223 (MMAR_3223) shares a high sequence iden-
tity of 79.2% with RNase AS.
Knockout ofM. marinum MMAR_3223 Affects Bacterial
Virulence In Vivo
To investigate the effect of RNase AS on virulence, we carried out
parallel experiments by injecting either M. marinum wild-type
strain or knockout strain MMAR_3223::Tn into zebrafish em-
bryos. By monitoring fluorescence at 5 days postinfection, we
observed that the infection ofMMAR_3223::Tnmutant is strongly
reduced in comparison toWT (Figures 1A and 1B). Quantification
of the infection level by fluorescence measurements shows an
infection of 4.7% in comparison to the WT (Figure 1C).
In this particular experiment, the bacterial input/embryo was
171 and 179 CFU for WT bacteria and MMAR_3223::Tn strain,
respectively; fluorescence data weremeasured on nine embryos
for WT and mutant.
To further confirm these data, we quantified by plating in an
independent experiment live bacterial counts (CFU) of embryos
infected with WT and MMAR_3223::Tn strain (Figure S2).
Consistent with the fluorescence data, the MMAR_3223::Tn
knockout strain shows strongly decreased CFU counts per
fish. In a final in vivo experiment, we also testedMMAR_3223::Tn
complemented with M. tuberculosis rv2179c. Clearly, virulence
of the MMAR_3223::Tn mutant strain is strongly attenuated
in vivo and the knockout can be complemented by
M. tuberculosis rv2179c (Figure 1D). Altogether, these data
strongly suggest that the gene products of M. marinumreserved
Table 1. Data Collection and Refinement Statistics
EuCl3
Derivative Apo
AMP
Complex
UMP
Complex
Data Collection
Space group P212121 P212121 P212121 P212121
a,b,c (A˚) 42.4, 76.7,
104.4
42.4, 77.1,
104.6
42.4, 77.0,
104.6
42.5, 76.8,
105.2
Resolution (A˚) 50.0–2.3 50.0–2.1 50.0–1.7 50.0–2.2
Average redundancy 12.0 (11.2) 6.6 (6.6) 4.9 (2.8) 6.8 (6.9)
Completeness (%) 100.0
(100.0)
99.9
(99.9)
99.9
(99.9)
99.9
(100.0)
Rmerge (%) 7.2 (45.0) 4.6 (46.0) 4.5 (45.1) 5.8 (46.0)
Average I/s(I) 25.1 (6.3) 31.8 (5.1) 25.8 (2.3) 26.9 (5.3)
Refinement
Resolution range (A˚) 15.0–2.1 15.0–1.7 15.0–2.2
Rwork, Rfree (%) 18.6, 23.2 18.5, 23.1 19.9, 24.0
No. atoms (protein,
water) rmsd
2,660, 360 2,660, 372 2,660, 360
Bond lengths (A˚) 0.02 0.02 0.02
Bond angles () 1.9 1.9 1.9
Values in parentheses are for highest resolution shells: 2.37–2.30 A˚,
2.14–2.10 A˚, 1.73–1.70 A˚, 2.24–2.20 A˚ for EuCl3 derivative, native, AMP
and UMP complexes, respectively. rmsd, root-mean-square deviation.
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Structure and Function of Mycobacterial RNase ASMMAR_3223 and M. tuberculosis rv2179c (i.e., RNase AS) are
indeed functional orthologs.
RNase AS Is a Dimer in Solution and in the Crystal State
Given the importance of RNase AS for bacterial virulence, we
expressed and purified RNase AS of M. tuberculosis for
biochemical and structural analyses. Structural features of
RNase AS in solution were checked using circular dichroism
(CD) and light scattering studies. CD spectra showed that RNase
AS adopts a well folded conformation, with two clear minima at
210 and 222 nm, indicative of an a-b structure (Figure S3A).
Analytical size-exclusion chromatography (SEC), coupled with
multiangle light scattering (MALS) was carried out to investigate
the oligomerization state of RNase AS in solution. The on-line
measurement of the intensity of the Rayleigh scattering as a
function of the angle as well as the differential refractive index
of the eluting peak in SEC was used to determine the molecular
weight (MW) (Figure S3B). This analysis produced an MW of
38,460 ± 231 Da, which corresponds to a dimeric organization
of the RNase AS protein in solution. RNase AS was crystallized
in the P212121 space group with one dimer in the asymmetric
unit. The structure was solved by single-wavelength anomalous
dispersion (SAD) analysis of Europium-derivatized crystals and
refined to a resolution of 2.1 A˚ (Table 1A). As observed in solu-
tion, the crystal structure shows that RNase AS is a dimer, with
each chain adopting a compact a/b fold (Figures 2 and S3C).
Overall Structure of RNase AS
Overall, RNase AS exhibits a dimeric hearth-like shape, with the
two monomers organized an 2-fold noncrystallographic axis.
Each monomer adopts a compact a/b fold in which a central
four-stranded b sheet with topology b5b1b2b3 is surrounded byStructure 22eight a helices (Figure 2). Dimer assembly involves the burial of
20% of the total surface area (3,080 A˚2) and the formation of
13 hydrogen bonds and 11 salt bridges. The interface features
complementary protuberances and cavities that come together
to allow the formation of a highly stable dimer, with a gain of
free energy of solvation DiG = 10.6 kcal/mol. Superposition of
the two RNase AS molecules in the asymmetric unit shows a
highly conserved structure, with overall backbone root-mean-
square deviation (rmsd) values of 0.4 A˚. An analysis of the degree
of conservation of surface residues of the protein, carried out
with ConSurf (Goldenberg et al., 2009) clearly identifies the cat-
alytic site clefts of RNase AS as two conserved clusters of resi-
dues, one in each lobe of the hearth-like structure, formed by
Asp6, Glu8, Asp95, and Asp145 (Figure 2). This finding univocally
classifies RNase AS among RNases belonging to the DEDD
superfamily, a large family of 30-50 exonucleases (Hsiao et al.,
2011). Among conserved residues in the catalytic site cleft
is also His140, which sorts RNase AS in the DEDDh family
(Figure 2). Surface conservation analysis also shows a high
sequence conservation for interface residues, like Tyr94,
Val97, and Met106 (Figure 2B). This finding suggests that the
dimer organization we observe both in solution and in the crystal
state is conserved in homologs sequences.
RNase AS Specifically Hydrolyses Poly(A) In Vitro
Enzymes of the DEDD superfamily have essential functions in
degrading DNA and/or RNA in prokaryotes and eukaryotes
(Hsiao et al., 2011; Zuo et al., 2007). We checked for the ability
of RNase AS to hydrolyze nucleic acids using HPLC chromatog-
raphy coupled with mass spectrometry. HPLC analysis after
incubation with poly(A) evidenced the accumulation of a de-
gradation product at 4 min. This product, identified both by its
retention time in HPLC and by liquid chromatography-electro-
spray ionization-mass spectrometry (LC-ESI-MS), is highly
distinctive of AMP (mass-to-charge ratio [m/z] = 348.01) (Fig-
ure 3A). Interestingly, ESI-MS results showed the sole accumu-
lation of AMP and not of polynucleotides. This indicates that
RNase AS is also active on short polynucleotides to fully degrade
them to AMP.
To experimentally prove that RNase AS belongs to the DEDDh
superfamily, we mutated the catalytic His140 to alanine (H140A)
and checked its activity against poly(A). Results clearly shows
that poly(A) remains fully undegraded after long incubation times
(Figure 3A). Most members of the DEDD exonucleases have
distinctive substrate preferences for specific structures or
sequences of nucleic acids (Hsiao et al., 2012; Hsiao et al.,
2011; Zuo et al., 2007). In order to understand the possible
specificity of the enzymatic reaction catalyzed by RNase AS,
we carried out parallel digestion experiments using poly(C),
poly(G), and poly(U) as possible substrates. Similar to experi-
ments with poly(A), the incubated mixtures were analyzed using
HPLC (Figure 3A). However, results were strikingly different from
those observed for poly(A). Indeed, the UV chromatograms
show that the total amounts of added polynucleotides were still
present in the mixtures and no extra peaks corresponding to
degradation products appeared after incubation (Figure 3B).
These data showed that RNase AS has a strong specificity
toward polyadenylate nucleotides. To corroborate this result,
we carried out HPLC and mass spectrometry analyses on the, 719–730, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 721
Figure 2. RNase AS Is a Dimer in the Crystal
State
(A) Cartoon representation of RNase AS crystal
structure. Chains A and B of the dimer are shown
in orange and green, respectively. The inset shows
an enlargement of one of the two catalytic sites,
with catalytic DEDDh residues shown in stick
representation.
(B) Degree of residue conservation on the protein
surface (Consurf analysis) plotted on chain B,
whereas chain A is shown as blue ribbon. Residue
coloring, reflecting the degree of residue conser-
vation, ranges from magenta (highly conserved) to
cyan (variable). Conserved residues in the cata-
lytic site and in the interface region are labeled.
See also Figure S3.
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Structure and Function of Mycobacterial RNase ASasymmetric oligonucleotide AAAACAAAAA. The choice of the
oligonucleotide sequence had a 2-fold purpose: (1) to confirm
that oligonucleotide degradation stops at C, and (2) to experi-
mentally determine direction of degradation. The oligonucleotide
was incubatedwith RNase AS and products were analyzed using
HPLC and mass spectrometry. HPLC profiles show the forma-
tion of a peak at 4 min corresponding to AMP and a further
peak at 11 min (Figure 3C). Mass spectrometry analysis allowed
us to establish that this peak corresponds to a degradation
product containing four A nucleotides and one C nucleotide
(Figure 3C). This finding evidences that RNase AS is a 30-50-
exoribonuclease.
RNase ASStrongly Discriminates betweenRNAandDNA
To investigate the specificity of RNase AS toward either RNA or
DNA sequences, we carried out digestion experiments with two
oligonucleotides: the dodeca-ribonucleotide A12 and the do-
deca-deoxyribonucleotide dA12. HPLC analyses were carried
out at increasing incubation times of protein-oligonucleotide
mixtures. Consistent with studies conducted with poly(A) (Fig-
ure 3A), A12 is fully degraded to AMP (Figure 4A). Degradation
is complete after 3 hr incubation, when the peak corresponding
to nondegraded A12 disappears completely (Figure 4A) and the
area of the peak corresponding to the degradation product rea-722 Structure 22, 719–730, May 6, 2014 ª2014 Elsevier Ltd All rights reservedches a stable value. Parallel HPLC
analyses carried out on the incubated
mixtures with dA12 show that a weak
peak, corresponding to dAMP, appears
after 3 hr incubation (Figure 4B). On the
other hand, monitoring the reaction in
time shows that the peak of nondegraded
dA12 does not significantly change even
after 72 hr (Figure 4B). These data show
that RNase AS is barely capable of
degrading dA12 and that kinetics is
extremely slow.
Structural Basis of RNase AS
Specificity: Crystal Structures of
RNase AS Complexes
In order to elucidate structural determi-
nants responsible for the observed strongspecificity of RNase AS for sequences of adenylate residues, we
determined the crystal structures of the enzyme in complex
with AMP and UMP. The analysis of the X-ray structure of the
AMP complex shows clear electron density for two AMP
molecules bound to the B chain of the enzyme (Figure 5A). On
the other hand, only one AMP molecule binds the A chain, due
to a crystallographic artifact (see Figure S4 and its legend for
details). Analysis of binding to chain B shows that the two AMP
moieties mimic the postcleavage state, after hydrolysis of the
phosphodiester bond between the two nucleotides. Therefore,
we denoted the two molecules as AMP(1) and AMP(+1) (Fig-
ure 5B). The two nucleotides establish interactions with both
chains of the enzyme (orange and green in Figure 5), a feature
that likely makes the enzyme active only as a dimer. Both are
embedded in narrow clefts by establishing hydrogen bonding
and hydrophobic interactions (Figure 5). Notably, the ribose
moiety of AMP(1) forms hydrogen bonds with the enzyme
both through its 20 and 30 OH. In particular, the 20OH binds the
backbone carbonyl carbon of Phe9, which also locks the posi-
tion of this sugar through van der Waals interactions (Figure 5C).
The 30OHof AMP(1) is hydrogen bonded to the backbone nitro-
gen of Phe9 and to the side chain Oε1 of Glu8. Also, the adenine
moiety of AMP(1) is stacked against the side chain of Trp46
(Figure 5B). These interactions make the 30OH atom of
Figure 3. RNase AS Selectively Hydrolyses Poly(A)
(A) HPLC profiles (280 nm) of poly(A) after 48 hr incubation with RNase AS
(dashed black), with the RNase AS mutant H140A (black) and in protein buffer
(gray). Electrospray ionization mass (inset) clearly identifies AMP (m/z 348.01)
as a reaction product.
(B) HPLC profiles (280 nm) of poly(U), poly(G), and poly(C) after 48 hr incu-
bation with RNase AS (upper curve) and protein buffer (bottom curve). An
arbitrary shift was applied for clarity.
(C) HPLC profiles (280 nm) after 48 hr incubation with RNase AS with the
polynucleotide AAAACAAAA (black) and in protein buffer (gray). Degradation
products are labeled. The reported value of m/z (1,559.49, negative ion)
is in agreement with the expected value for the product AAAAC
([C49H61N23O29P4-H]
, m/z 1,559.05).
Figure 4. RNase AS Strongly Discriminates between RNA and DNA
(A) HPLC profile (280 nm) of A12 after 3 hr incubation with RNase AS (upper
curve) and with the protein buffer (bottom curve).
(B) HPLC profiles after incubation of dA12 with RNase AS, in the time range
3–72 hr. In both panels, UV profiles after incubations were arbitrarily upshifted,
for clarity.
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Structure and Function of Mycobacterial RNase ASAMP(1) completely solvent inaccessible, a feature that con-
firms that, like other ribonucleases of the DEDD family, RNase
AS is 30-50 exonuclease (Zuo and Deutscher, 2002a, 2002b,
2002c). Likely, RNase AS tightly locks the nucleotide at the 30
end of the polynucleotide, thus bringing the first phosphodiester
bond to be cleaved in the vicinity of the catalytic residues
(Figure 5C).Structure 22As observed for other members of the DEDD family (Hsiao
et al., 2011; Zuo et al., 2005), two divalent (Mg2+) ions are present
in the catalytic site and stabilize nucleotide binding (Figure 5C).
The first Mg2+ ion (MGA) coordinated by the side chain of the
catalytic Asp6, by the 20 and 30OH atoms of the ribose moiety
of AMP(+1) and by the phosphate moiety of AMP(1). Further
coordination sites are occupied by water molecules. The second
Mg2+ ion (MGB) is coordinated by the side chains of catalytic
Asp6, Glu8, and Asp145 and by the phosphate moiety of
AMP(1). Notably, the full involvement of 20OH atoms of both
nucleotides in hydrogen bonding interactions, either with the
protein structure or with MGA, provides a structural explanation
for the strong preference of RNase AS for RNA rather than DNA
(Figures 4 and 5).
An interesting feature of AMP(+1) is that its binding site is
composed of both chains of the enzyme, as its adenine moiety
is fully buried by establishing interactions with the side chains
of Met106 and Arg115 of the adjacent RNase AS chain (chain
A, orange in Figure 5C). In particular, the NH2 group of the
adenine base of AMP at the (+1) site forms a hydrogen bond
with the backbone carbonyl oxygen of Met106 (Figure 5C).
Because a carbonyl oxygen can act only as a hydrogen bond
acceptor, this interaction poses serious restrictions on the nucle-
otide that can bind to the (+1) site., 719–730, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 723
Figure 5. Binding Mode of AMP Nucleotides
(A) Omit (Fo-Fc) electron density map, contoured at 2.0 s, of AMP(1) and
AMP(+1) nucleotides.
(B) Stick representation of AMP(1) and AMP(+1) in the catalytic site cleft of
RNase AS. Cartoon and surface representations of A and B chains of RNase
AS are shown in orange and green, respectively.
(C) Hydrogen bonding interactions and coordination with Mg2+ sites (MGA and
MGB, in yellow) of AMP(1) and AMP(+1) with the enzyme.
See also Figure S4.
Figure 6. RNase AS Does Not Degrade Polyinosine
HPLC profiles (280 nm) of polyinosine after 48 hr incubation with RNase AS
(black) and in protein buffer (blank, gray). An arbitrary shift was applied for
clarity. The inset shows the chemical structure of inosine mononucleotide.
Structure
Structure and Function of Mycobacterial RNase ASA Single Hydrogen Bond Is Responsible for A Specificity
To corroborate our hypothesis that the adenine moiety on the
nucleotide (+1) is the determinant for specificity of recognition
by the enzyme and that its NH2 group is a strict requirement as
a hydrogen bond donor, we performed HPLC studies using
polyinosine, a polymer of an intermediate of AMP biosynthesis,
which holds all characteristics of AMP but carries a nucleobase
having in its predominant keto form an oxygen in place of the
adenine NH2 group (Figure 6). As predicted, the results clearly
show that RNase AS is unable to degrade polyinosine. Indeed,
UV chromatograms of incubatedmixtures showed no peaks cor-
responding to degradation products (Figure 6).
To investigate the binding mode of pyrimidine nucleotides, we
also determined the crystal structure of RNase AS in complex
with UMP. Electron density maps clearly showed the presence
of UMP at the site (1) of both chains A and B, whereas no elec-
tron density was observed for the site (+1) of chain B, likely due to
low binding affinity of UMP for this site (Figure 7A). The observed
conformation of UMP(1) is superimposable with that of
AMP(1), with the pyrimidine base forming a stacking interaction
with the side chain of Trp46 (Figure 7B). However, consistent724 Structure 22, 719–730, May 6, 2014 ª2014 Elsevier Ltd All rightswith the observed binding mode of AMP, no electron density is
observed for UMP in the (+1) site, this suggesting that inter-
actions observed for AMP with Met106 and Arg115 are unfavor-
able for pyrimidine binding. This result explains the inability of
RNase AS to degrade poly(U) and poly(C) (Figure 2B) and sug-
gests that tight binding to both (1) and (+1) sites is necessary
to hold oligonucleotides in the right conformation for catalysis.
RNase AS Structurally Resembles RNase T
A search for similar folds in structural data bases revealed a
strong structural relationship between RNase AS and subunit
RNase T from E. coli (Protein Data Bank [PDB] code 3V9X, Z =
23.0 and rmsd = 4.1 A˚ upon overall backbone superposition),
despite there being low sequence identity between the two,
i.e., 13% (Figure 8). Compared to RNase T, RNase AS has
several deletions, including the N- and C-terminal ends, which
are 12–14 residues shorter in RNase AS (Figure S5). Overall,
RNase AS displays a more compact structure than RNase T
(Figure 8), with extra intersubunit interactions formed in RNase
AS by the loops L1, between b strands b1 and b2 and by the a
helix H6 (Figure 8A). An interesting structural difference involves
the binding site of AMP(+1). In RNase AS, Met106 is preceded
by a proline residue (Pro105). Consequently, a long a helix
embedding residues 121–136 of RNase T is broken in two heli-
ces in RNase AS (H5 and H6), to contribute to form the cleft host-
ing AMP(+1) adenine base (Figures 8A and S6).
Both RNase AS and RNase T are highly negatively charged
proteins, with theoretical pI values of 5.3 and 5.2, respectively.
However, the two proteins display uneven electrostatic potential
surfaces (Figures 8B and 8C). Indeed, RNase AS does not exhibit
a characteristic positively charged patch (NSB patch) of RNase T
(Figure 8C), which has been shown to be involved in nucleotide
binding and is associated with the preference of RNase T to
bind long nucleotides (Zuo et al., 2007). Instead, a positivelyreserved
Figure 7. Binding Mode of UMP
(A) Omit (Fo-Fc) electron density map, contoured at 2.0 s, of UMP nucleotide
at the (1) site of RNase AS.
(B) Superposition of complexes of RNase ASwith AMP (navy) and UMP (cyan).
Whereas UMP does not bind the (+1) site, it shares the same conformation and
hydrogen bonding interactions with RNase AS in the (1) site. Cartoons are
shown in light green (UMP complex) and forest green (AMP complex). Binding
of either UMP or AMP at the (1) site induces slightly different conformations
of the side chains of Trp46, His140, and Glu8, which are shown in stick rep-
resentation.
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Structure and Function of Mycobacterial RNase AScharged patch is located just below the catalytic cleft and is
formed by Arg131 and Arg135 (Figure 8B). These differences
likely account for the different preferences of the two enzymes
for oligonucleotide of different lengths. Consistently, LC-ESI-
MS show only the accumulation of AMP upon degradation of
poly(A) and not of larger nucleotides. This suggests that, different
from RNase T (Zuo et al., 2007), RNase AS is also active on short
nucleotides.
DISCUSSION
Mycobacteria rely on their complex cell envelope for shape and
structure. Also, the low permeability of the cell envelope appears
to be essential for mycobacterial survival in the host. Therefore,
the coordination of enzymes affecting cell envelope composition
is a critical process for bacterial survival. By screening genes
affecting cell envelope of M. marinum, we identified a proteinStructure 22with a close homolog inM. tuberculosis, here denoted as RNase
AS. In this article, we show that RNase AS is a 30-50 exoribonucle-
ase with a strong specificity for polyadenylate sequences. By
combining X-ray crystallography with HPLC chromatography,
light scattering, mass spectrometry, and microbiology studies,
we characterized the structure and the functional properties
in vitro and in vivo of RNase AS and highlighted an important
role of this enzyme in bacterial virulence.
The crystal structures of RNase AS, determined in its free and
complexed forms, highlighted a structural resemblance with
RNase T from E. coli (Zuo et al., 2007) that could not be predicted
based on sequence alignments. Structural features of the
enzyme resemble those of an independently determined struc-
ture reported in the Protein Data Bank while our functional char-
acterization was ongoing (PDB code 4HEC)(Abendroth et al.,
2014). Strong conservation of a characteristic patch of residues
on the structure surface (the DEDD patch) shows that RNase AS,
like RNase T, belongs to the superfamily of DEDD exonucleases
(Figure 2). Consistently, phylogenetic analysis shows that RNase
AS clusters with the RNA-editing DEDDh exonucleases such as
REX and the Poly(A) nuclease PAN (Abe et al., 2010; van Hoof
et al., 2000; Yoda et al., 2013). Because most members of the
DEDD exonuclease family have distinctive substrate preferences
for specific structures or sequences of nucleic acids, we
analyzed the in vitro activity of RNase AS in degrading polynucle-
otides (Hsiao et al., 2011). Results evidenced a strong specificity
of the enzyme for RNA sequences, rather than DNA sequences.
Also, RNase AS readily degrades polyadenylate but no other
homopolynucleotides (Figure 3). The crystal structure of RNase
AS in complex with AMP provides a straight forwardmechanistic
explanation for the observed specificity. Namely, two AMP
molecules bind to the catalytic site cleft of the enzyme in posi-
tions corresponding to that upstream (+1) and downstream
(1) the cleavage site. Among interactions stabilizing the
AMP(+1) conformation, a single hydrogen bond between the
NH2 group of the adenine moiety and the backbone carbonyl
oxygen of Met106 forces restrictions on the nature of this
base. Indeed, even guanine would not fulfill the requirement of
having a hydrogen bond donor at the position corresponding
to adenine NH2 group. Consistently, we show that the enzyme
is unable to degrade polyinosine, a polynucleotide in which the
adenine NH2 group is replaced by a carbonyl oxygen, unable
to act as a donor in hydrogen bonding interactions (Figure 6).
This simple recruitment mechanism of RNase AS differs from
that proposed for RNase T (Hsiao et al., 2011). Indeed, the strong
preference for polyadenylate is also held by other RNases of the
DEDD family, but the structural basis for this specificity has only
been recently explained for RNase T (Hsiao et al., 2011). By pre-
paring complexes of RNase T with nonpreferred single strand
DNA ending with cytosine (C), it was shown that the binding of
the 30 C induces a conformational change disrupting the active
site structure and directing the catalytic His181 away from the
catalytic center (Hsiao et al., 2011). In RNase AS, the a helix
H6, embedding Met106, represents one of the several structural
differences with RNase T. Indeed,Met106 is a one-residue inser-
tion preceded by a proline residue (Pro105) in RNase AS (Fig-
ure S5). Consequently, a long a helix embedding residues 121–
136 of RNase T is disrupted in RNase AS, to contribute to form
the cleft hosting AMP(+1) adenine base (Figures 8A and S6)., 719–730, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 725
Figure 8. Structural Comparisons between
RNase AS and RNase T
(A) Superposition of RNase AS structure (orange)
to that of RNase T (magenta). The inset shows
a detail of structural differences of the region
involving the AMP(+1) binding pocket.
(B,C) Electrostatic potential surfaces of RNase AS
and RNase T, respectively. Positive potential is
drawn in blue, negative in red.
See also Figures S5 and S6.
Structure
Structure and Function of Mycobacterial RNase ASThis structural difference renders the mechanism of nucleotide
selection by RNase AS much simpler. Consistent with this
recruitment mechanism, the crystal structure of RNase AS in
complex with UMP shows the presence of this nucleotide only
at the (1) site and not at the (+1) site, which dictates specificity
(Figure 7), thus explaining the inactivity of the enzyme toward
poly(U) and poly(C).
The 30-ends of both prokaryotic, including mycobacterial and
eukaryotic mRNA are polyadenylated, although features of
prokaryotic and eukaryotic polyadenylation are distinct. For
example, addition of poly(A) tails increases the stability of tran-
scripts in eukaryotes, whereas it promotes instability in prokary-
otes (Adilakshmi et al., 2000; Mohanty et al., 2012). The poly(A)
tail is an important structural element affecting translational
efficiency of mRNAs. Therefore, deadenylation is the first and
rate-limiting step of mRNA turnover and an important control
point during gene expression (Mohanty and Kushner, 2013).
Like other members of the DEDD family, RNase AS is likely
involved in mRNA turnover through processing of 30-ends of
mRNA. However, the transcription of which genes are regulated
by RNase AS is hitherto unknown.
We investigated the effect of RNase AS on virulence, by inject-
ing the knockout strain MMAR_3223::Tn (being MMAR_3223
highly homolog to RNase AS) of M. marinum into zebrafish
embryos. Notably, we observed that knockout leads to a dra-
matic depression of bacterial virulence in vivo and that the
knockout can be complemented by the gene encoding for RNase
AS (Figure 1). What is the molecular cause of the decreased viru-
lence is still under investigation, but it is known that cell envelope
components may play a crucial role in virulence. For example,726 Structure 22, 719–730, May 6, 2014 ª2014 Elsevier Ltd All rights reservedcapsular a-glucan interacts with phago-
cytic complement receptor 3 (CR3), thus
mediating binding of M. tuberculosis to
host immune cells (Cywes et al., 1997;
Ehlers and Daffe´, 1998). It also blocks
dendritic cell (DC) functions (Gagliardi
et al., 2007) and interacts with the
C-type lectin immune receptor DC-SIGN
(Geurtsen et al., 2009). Consistently, a
M. tuberculosis mutant with decreased
capsular a-glucan levels displayed
reduced virulence in vivo inmice (Sambou
et al., 2008). The RNase AS-mediated
deadenylation process is likely involved
in determining mRNA stability of multiple
transcripts and is therefore capable to
influence additional mycobacterial viru-lence determinants. Consistently, the gene region of RNase AS
is clustered with genes that affect themycobacterial cell surface.
The gene rv2181 (orthologous of MMAR_3225), located next to
the operon rv2179c-2180c, codes for an a-1-2 mannosyltrans-
ferase from the glycosyltransferase family C (GT-C) (Kaur et al.,
2006; Mishra et al., 2011) with a functional dual role in mannose
capping of lipoarabinomannan (LAM) and mannan-core branch-
ing of LAM and lipomannan (LM) (Kaur et al., 2008). Its inactiva-
tion leads to decreased virulence ofM. marinum in the zebrafish
(Stoop et al., 2013). However, we observed nodifferences in LAM
or LM biogenesis (data not shown), suggesting that LAM and LM
are not likely responsible for the reduced virulence observed in
M. marinum RNase AS mutant.
Future efforts should be directed toward identifying the genes
responsible for the dramatic impact on bacterial virulence, which
are deadenylated by RNase AS (Figure 1) and whose deadenyla-
tion is likely critical to their stability. A full comprehension of the
molecular details of RNA maturation processes will be essential
to devising strategies for targetedmodulation of RNA processing
for therapeutic purposes. In this context, the availability of the
crystal structure of RNase AS, whose inactivation has strong
functional implications, aids in rational drug design and provides
a strong practical advantage in high-throughput docking and
lead optimization studies.EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of RNase AS
The gene coding for RNase AS fromM. tuberculosis (rv2179c) was cloned into
a pETM11 vector to express a His6-tag RNase AS fusion protein. For protein
Structure
Structure and Function of Mycobacterial RNase ASexpression, the plasmid was transformed into E. coli BL21 (DE3) pLysS cells.
10 mL overnight culture of BL21 (DE3) pLysS E. coli/pETM11/His-tag-RNase
AS was inoculated in 1l of Luria-Bertani (LB) medium, supplemented with
50mg/ml kanamycin and 33 mg/ml chloramphenicol, and subsequently grown
at 37C. When the cultures reached an OD600 0.65, the expression of the
recombinant protein was induced by adding 0.4 mM IPTG at 20C and incu-
bated for 16 hr.
Cell pellets were resuspended in lysis buffer (10 mM imidazole, 20 mM
HEPES pH 7.5, 300 mM NaCl, 5% glycerol, 10 mM MgCl2, 0,01% CHAPS,
1 mM DTT, pH 7.5), including a protease-inhibitor cocktail (Roche Diagnostic)
and DNase 20 mg/ml. Subsequently, suspensions were incubated on ice for
30 min and additionally, the cells were sonicated and centrifuged at
30,000 3 g for 30 min.
The protein was purified from a clarified lysate by affinity chromatography,
using a 5 ml Ni-NTA (Ni2+-nitrilotriacetate) column (GE Healthcare) with an
‘‘on-column cleavage’’ procedure. In detail, the supernatants were loaded
onto an affinity column and subsequently washed with buffer A (30 mM imid-
azole, 20 mM HEPES pH 7.5, 300 mM NaCl, 5% glycerol, 10 mM MgCl2,
0.01% CHAPS, 1 mM DTT, pH 7.5). Next, the TEV protease (TEVprot-RNase
AS ratio 1:30) was added to the column and incubated for 16–20 hr at 20C.
Then, the target protein (His-tag cleaved RNase AS) was eluted with the
same buffer A, leaving His containing elements and the protease on the
column. Subsequently, RNase AS was purified by dialysis overnight at 20C
against buffer (20 mM HEPES pH 7.5, 300 mM NaCl, 5% glycerol, 5 mM
MgCl2, 0,0025% CHAPS, 1 mM DTT, pH 7.5) and was analyzed by SDS-
PAGE for protein homogeneity.
The expression vector encoding the H140Amutation was generated by site-
directed mutagenesis of wild-type plasmid pETM11-RNaseAS using the
Stratagene QuikChange kit and the mutagenic primers: forward, 50-CGG
CCACGCGACGTCGCCGACGCGCTGGTCGATG-30; reverse, 50-CATCGAC
CAGCGCGTCGGCGACGTCGCGTGGCCG-30. DNA sequencing confirmed
themutation into the recombinant plasmid sequence. Expression and purifica-
tion of the mutant were performed in the same conditions as for the unmutated
enzyme.
Crystallization, Data Collection, and Processing
Crystallization trials were performed at 293 K using the hanging-drop vapor-
diffusion method. Preliminary crystallization conditions were set up using a
robot station for high throughput crystallization screening (Hamilton STARlet
NanoJet 8+1) and commercially available sparse-matrix kits (Crystal Screen
kits I and II, Hampton Research, Index). Optimization of the crystallization
conditions was performed manually by tuning protein and precipitant concen-
trations. Best crystals were grown using a protein concentration of 14mg/ml in
0.1 M HEPES pH 7.5, 10% w/v polyethylene glycol 8,000, 8% v/v ethylene
glycol. For structure solution, Europium chloride derivative crystals were
prepared by soaking a native crystal in a solution containing 9 mM EuCl3,
0.1 M HEPES pH 7.5, 10% w/v polyethylene glycol 8,000, 8% v/v ethylene
glycol for 2 hr. A single-wavelength anomalous diffraction experiment (SAD)
was recorded in-house at 100 K using a Rigaku Micromax 007 HF generator
producing Cu Ka radiation and equipped with a Saturn944 CCD detector.
The data sets were scaled and merged using HKL2000 program package
(Otwinowski and Minor, 1997) (Table 1). Crystals of complexes of RNase AS
with AMP and UMP were prepared by soaking crystals of native protein in a
solution containing AMP or UMP at 20 mM. Diffraction data were collected
using the same protocol used for the native crystal.
Structure Determination and Refinement
Phasing was achieved using in-house SAD data, using a previously adopted
protocol (Ruggiero et al., 2011; Squeglia et al., 2014). Using these data, both
SHELXD (Sheldrick, 2008) and SOLVE (Terwilliger, 2004) identified five Euro-
pium ions. Phases, improved by phase extension and density modification
by RESOLVE (Terwilliger, 2004) and wARP (Langer et al., 2008), allowed us
to trace nearly the entire molecule structure. Crystallographic refinement
was carried out against 95% of the measured data using the REFMAC pro-
gram implemented in the CCP4 program suite (Potterton et al., 2003). The
remaining 5% of the observed data, which was randomly selected, was
used in Rfree calculations to monitor the progress of refinement. Structures
were validated using the program PROCHECK (Cheng et al., 2008). StructuresStructure 22of complexes with AMP and UMP were determined using Fourier difference
techniques and refined using REFMAC (Table 1). Structures of free RNase
AS and its complexes with AMP and UMP were deposited in the PDB with
codes 4OKJ, 4OKE, and 4OKK, respectively.
CD Spectroscopy
To analyze the conformational state of RNase AS, far-UV CD spectra
were registered at 20C. All CD spectra were recorded with a Jasco J-810
spectropolarimeter equippedwith a Peltier temperature control system (Model
PTC-423-S). Molar ellipticity per mean residue, [q] in deg cm2 3 dmol1, was
calculated from the equation: [q] = [q]obs 3 mrw 3 (10 3 l 3 C)1, where [q]
obs is the ellipticity measured in degrees, mrw is the mean residue molecular
mass (116.0 Da), C is the protein concentration in g 3 l1, and l is the optical
path length of the cell in cm. Far-UVmeasurements (190–260 nm) were carried
out at 20C using a 0.1 cm optical path length cell and a protein concentration
of 0.2 mg 3 ml1.
Mass Spectrometry and HPLC Analyses
RNase AS 2 mMwas incubated for 48 hr at 4C with 200 mM poly(A) (concen-
tration expressed in A nucleotides) in protein buffer (50 mM Tris HCl, 200 mM
NaCl, 5% glycerol, 1 mM DTT, 0.01% CHAPS, 12.5 mM MgCl2, pH 7.8). As
control experiments, the protein alone and polynucleotides (poly(A), poly(U),
poly(G), poly(C)) 200mMwere stored at 4C in the protein buffer for 48 hr. After
incubations, all samples were analyzed by LC-MS, performed on an MSQ
mass spectrometer (Thermoelectron) equipped with an ESI source operating
at 3 kV needle voltage and 320C and with a complete Surveyor HPLC system,
comprising an MS pump, an autosampler, and a PDA detector, by using a
Phenomenex Jupiter C18 300 A˚ column (5 mm, 4.6 3 250 mm) column.
Gradient elution was performed (monitoring at 280 nm) by building up a linear
gradient from 2% to 50% of buffer B (0.05% TFA in acetonitrile) in buffer A
(0.05% TFA in water) over 15 min with a flow rate of 0.8 ml/min. Free mononu-
cleotides were used as reference for mass spectrometry.
Degradation experiments on oligonucleotides AAAACAAAAA, A12 and dA12
were carried out in the same experimental conditions used for polynucleo-
tides. The ESI mass spectrum for the AAAACAAAAA degradation product
was obtained using a LCQ DECA ion trap instrument (Thermoelectron), oper-
ating in negative ionmode. The entrance capillary temperature was 280C, the
source voltage was 4.5 kV and the capillary voltage was 15 V. The sample
was dissolved in 20 mM ammonium acetate (pH = 7.4) to obtain a 31 mM con-
centration of oligonucleotide.
Multiple Angle Light Scattering Experiments
Purified RNase AS was analyzed by size-exclusion chromatography (SEC)
coupled to a DAWN MALS instrument (Wyatt Technology) and an Optilab
rEX (Wyatt Technology). Six hundred micrograms of sample was loaded a
S200 10/30 column, equilibrated in 50 mM Tris HCl, 200 mM NaCl, 5% glyc-
erol, 1 mM DTT, 0.01% CHAPS, 12.5 mM MgCl2, pH 7.8. A constant flow
rate of 0.5 ml/min was applied. The on-line measurement of the intensity of
the Rayleigh scattering as a function of the angle as well as the differential
refractive index of the eluting peak in SEC was used to determine the weight
average molar mass (Mw) of eluted protein, using the Astra 5.3.4.14 (Wyatt
Technologies) software.
Sequence Conservation Studies
Sequence conservation studies were carried out using the software ConSurf
(Goldenberg et al., 2009). The homolog search algorithm CSI-BLAST
was used to retrieve sequences from the UNIREF-90 sequence database
using an E value cutoff of 0.001 and minimal sequence identity of 35% (150
sequences). Sequences were aligned using MAFFT-L-INS-I alignment
method.
Bacterial Strains and Growth Conditions
M. marinum (strain Mma20) (van der Sar et al., 2004) was grown at 30C
on Middlebrook 7H10 agar plates (Difco) or in liquid medium (7H9 Middle-
brook) medium supplemented with 10% albumin-dextrose-catalase (ADC;
BD Bioscience) and 0.05% Tween-80. M. smegmatis mc2155 was likewise
grown but at 37C. For bacterial strains grown under selective pressure,
hygromycin or kanamycin were added at 50 mg/ml. The E. coli strains were, 719–730, May 6, 2014 ª2014 Elsevier Ltd All rights reserved 727
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Structure and Function of Mycobacterial RNase ASgrown at 37C in LB broth or on LB agar (Difco). When required, hygromycin
was supplemented at 100 mg/ml.
Transposon Mutagenesis and Capsular a-Glucan Mutant Screen
Transposon mutagenesis was performed according to Abdallah et al. (2006).
The obtained libraries of M. marinum and M. smegmatis were screened in a
double filter assay for expression of capsular a-glucan. Concisely, the
mixture of bacteria and transposon-carrying mycobacteriophages was incu-
bated and plated on nitrocellulose filters (Millipore HATF08250) on top of
7H10 plates supplemented with kanamycin and were grown till visually
discernible colonies appeared. Subsequently, the filters were removed and
placed on top of new filters covering fresh 7H10 plates and incubated at
30C or 37C. During this period soluble, secreted cell surface components
including capsular glucan but not intact bacteria diffuse from the top to the
bottom filters. Next, the bottom filter was incubated with monoclonal anti-
body (mAb) IV58B6 against glycogen (Baba, 1993); this mAb cross-reacts
with mycobacterial capsular glucan (Sani et al., 2010). After DAB/CNPO
staining, filters were checked for colonies that showed more or, in contrast,
less capsular a-glucan as compared to WT strain. The transposon insertion
sites of the mutant strains were identified by ligation-mediated (LM) PCR
as earlier described (Abdallah et al., 2006); for primer and linker sequences
used see Table S2.
Construction of a Genetically Complemented Strain in M. marinum
Mutant M. marinum MMAR_3223::Tn was complemented with its
M. tuberculosis rv2179c ortholog. In short, primers were designed (see Table
S2) and rv2179c was amplified from M. tuberculosis genomic DNA by PCR.
The PCR products were purified and digested with BamHI and NheI. pSMT3
E. coli-Mycobacterium shuttle vector was purified from E. coli strain Dha
and digested with BamHI and NheI. The digested plasmid and the insert
were ligated by T4 ligase and then transformed into E. coli XL-10 by heat
shock; in this plasmid, rv2179c is located downstream of a lac promotor.
The transformants were selected on LB plates supplemented with hygromycin
and the pSMT3 complementation plasmid was confirmed by sequencing. This
plasmid was electroporated into M. marinum MMAR_3223::Tn. The comple-
mented strain (coded M. marinum MMAR_3223::Tn+rv2179c) was confirmed
by PCR (Table S2).
Zebrafish Embryo Infection and Quantification of Bacterial Infection
Level
M. marinum (Mma20) wild-type and M. marinum MMAR_3223::Tn
expressing the fluorescent marker mcherry were grown to the logarithmic
phase and microinjected into Danio rerio zebrafish embryos and, sub-
sequently, the infection was analyzed according to Stoop et al. (2011).
Briefly, zebrafish embryos were inoculated in the caudal vein and the bacte-
rial injection load was determined by plating on 7H10. At 5 days after the
bacterial injection (dpi), the infection was monitored by fluorescence micro-
scopy (Leica MZ16FA) and subsequent bright-field and fluorescence pictures
were created by a specialized camera (Leica, DFC420C). The quantification
of the bacterial infection level in these embryos was monitored in two
different ways. In real-time, it was analyzed with fluorescent imaging soft-
ware and second, zebrafish embryos were disrupted and plated for the
determination of colony forming units (CFUs) as published earlier (Stoop
et al., 2011). The zebrafish experiments were performed according the
guidelines of the Dutch animal welfare laws and were done at two indepen-
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